Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
American Journal of Cancer Research|June 14, 2016
Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in miceXingkai Liu, Ping Zhang, Robert C Martin, et al.Oncology Letters|January 25, 2019
Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosisXingkai Liu, Chang Su, Jing Xu, et al.Molecules (Basel, Switzerland)|June 19, 2024
Trichostatin A Promotes Cytotoxicity of Cisplatin, as Evidenced by Enhanced Apoptosis/Cell Death MarkersYang Zhou, Qun Luo, Fangang Zeng, et al.International Journal of Biological Sciences|July 30, 2021
Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO miceYouxi Yu, Xiaoju Shi, Qianqian Zheng, et al.Journal of Experimental & Clinical Cancer Research : CR|July 6, 2018
Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liverGuozhen Cui, Robert C Martin, Hang Jin, et al.American Journal of Cancer Research|July 16, 2015
Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformationQuan Zhang, Yan Li, Tingting Liang, et al.International Journal of Biological Sciences|April 21, 2015
ER stress and autophagy dysfunction contribute to fatty liver in diabetic miceQuan Zhang, Yan Li, Tingting Liang, et al.Molecules (Basel, Switzerland)|February 24, 2024
Strophanthidin Induces Apoptosis of Human Lung Adenocarcinoma Cells by Promoting TRAIL-DR5 SignalingXiao Tian, Liangzhen Gu, Fangang Zeng, et al.Theranostics|September 15, 2020
Lack of FGF21 promotes NASH-HCC transition <i>via</i> hepatocyte-TLR4-IL-17A signalingQianqian Zheng, Robert C Martin, Xiaoju Shi, et al.Signal Transduction and Targeted Therapy|August 8, 2024
Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosisHan Yan, Wenjun Liu, Rui Xiang, et al.Pageof 4